You are here: Industry Insights > Alvotech

News List

Alvotech, Cipla Gulf to commercialise key biosimilar in few emerging markets biospectrumasia
July 29, 2019
For the commercialization of AVT02, an adalimumab biosimilar, in select emerging markets.
Alvotech, Fuji Pharma Sign Commercialization Agreement contractpharma
April 15, 2019
For the exclusive partnership and supply to commercialize Alvotech’s ustekinumab biosimilar (Stelara) in Japan...
Alvotech Completes U.S. $300M Financing Deal firstwordpharma
January 23, 2019
Alvotech announced today that it has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance of existing debt and the further development of Alvotech’s biosi
Alvotech Completes U.S. $300M Financing Deal firstwordpharma
January 23, 2019
Alvotech announced today that it has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance of existing debt and the further development of Alvotech’s biosi
Alvotech, Fuji Pharma partner for biosimilars biospectrumasia
November 21, 2018
Partnership gives Fuji Pharma a leading position in the Japanese biosimilar market
Alvotech receives manufacturing licence for its biopharmaceutical facility cphi-online
November 15, 2018
Alvotech has received a manufacturing licence from the Icelandic Medicines Agency for its biopharmaceutical facility in Reykjavik, Iceland. The 13,000-m² facility.
Changchun High, New Technology form $200 M JV biospectrum
September 25, 2018
Changchun will fund the JV with $100 million while Alvotech will contribute $10 million plus six drug licenses valued at $90 million.

Previous page 1 2 Next page